Gain global insights on the optimal care of patients with advanced EGFR-mutated NSCLC in this comprehensive online program including a Podcast and an on-demand Webcast of a CCO live Webinar, both featuring medical oncologists from the United States and Europe, along with expert-authored commentaries and a regularly updated downloadable slideset.
In this expert commentary, gain insights into barriers to osimertinib access worldwide along with future directions in the management of patients with advanced EGFR-mutant NSCLC.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.